BRANCOUS LP1 CALLS ON BRAEMAR’S BOARD TO STOP ATTACKING SHAREHOLDERS, DISTRIBUTE EXCESS CASH AND RENEGOTIATE THE ASHFORD PAYMENT

Brancous LP1, a shareholder of Braemar Hotels & Resorts (BHR), is pressing the Board to reduce a $480M Ashford termination payment and claims the Board is pursuing a “stealth liquidation” by selling over 30% of gross asset value to trigger a Change of Control payment. The letter estimates the Ashford payout economics imply a roughly $7.00/share “Monty Tax,” nearly 3x the stock’s current trading level, and argues the Board should instead negotiate the fee and return excess cash (about $100M) via a special dividend of at least $1.00/share. Brancous also calls for a shareholder meeting to elect a truly independent Board, accusing the current directors of wasting resources on disputes with shareholders.

Analysis

This is less about the public disagreement and more about the capital structure of the dispute: BHR equity is increasingly being treated as a residual claim behind a potentially very large control fee. That matters because once the market believes asset-sale proceeds can be diverted before common equity participates, NAV-based bulls stop underwriting the stock as a liquidating estate and start pricing it like a litigation overhang with optional upside.

The near-term trade is driven by event sequencing, not fundamentals. Over the next 1-3 months, the important catalysts are whether the board is forced into a shareholder vote, whether there is a negotiated fee reduction, and whether asset sales accelerate enough to raise covenant or timing risk. If the board keeps selling assets without a clean settlement, the common can underperform even if reported liquidity looks adequate, because the market will discount the probability that proceeds are pre-committed elsewhere.

Second-order effects spill beyond BHR: any externally managed lodging REIT with a conflicted fee structure can pick up a governance discount if investors decide this template is repeatable. The contrarian view is that the stock may already be pricing in a bad outcome, so a credible fee reset or special dividend could squeeze shorts quickly; but until that happens, the equity behaves like a binary event-driven instrument rather than a cash-yield story. Falsifiers are straightforward: a binding termination-fee reduction, a board-led special dividend that survives covenant review, or a shareholder process that meaningfully changes control.

Key Decisions for Investors

• Short BHR on any relief rally tied to settlement rumors; 1-3 month horizon. Risk/reward is attractive if the market keeps discounting a fee-funded liquidation path, but cover immediately on an announced Ashford fee cut or special dividend.
• Prefer BHR put spreads over outright short if borrow tightens; the thesis is a downside re-rate from governance overhang, with defined risk if activists force a fast resolution.
• Pair trade: long XHR or HST vs short BHR to isolate idiosyncratic governance risk from sector beta. Best entry is after a sharp headline-driven bounce, when implied volatility is still elevated but the legal path remains unresolved.
• Set a catalyst watch on any formal shareholder meeting notice, board refresh, or public covenant analysis. If no fee renegotiation is disclosed within 30-60 days, treat the stock as a sale-process laggard and maintain bearish exposure.